Thirty-Nine Years Later: A Case Report and Literature Review of Delayed Pleural and Pericardial Effusions After Chest Radiotherapy for Non-Hodgkin Lymphoma
- PMID: 40225533
- PMCID: PMC11993311
- DOI: 10.7759/cureus.80528
Thirty-Nine Years Later: A Case Report and Literature Review of Delayed Pleural and Pericardial Effusions After Chest Radiotherapy for Non-Hodgkin Lymphoma
Abstract
Radiation therapy (RT) is a common treatment for non-Hodgkin lymphoma (NHL) but can lead to long-term pulmonary and cardiovascular complications. Delayed radiotherapy-related pleural effusion (DRPE) and pericardial effusion are rare sequelae, with few cases reported. This case highlights recurrent pleural and pericardial effusions nearly 40 years after chest RT, underscoring the need for ongoing surveillance in cancer survivors. A 51-year-old female with a history of nodular sclerosing NHL in remission after RT in 1977 presented in 2016 with recurrent bilateral pleural and pericardial effusions. Despite multiple interventions, including pericardiocentesis, thoracenteses, and pleural catheter placement, her effusions persisted. An extensive workup ruled out malignancy, infection, and autoimmune causes, ultimately attributing the effusions to radiation-induced lung injury. Despite ongoing management, she was discharged to hospice care. DRPE is a diagnostic challenge due to its delayed onset, sometimes appearing decades after RT. It can present with variable pleural fluid characteristics. Radiation-induced lung injury is a known complication of thoracic RT, with risk factors including radiation dose and pre-existing pulmonary conditions. Management is symptomatic, with treatments such as NSAIDs, corticosteroids, diuretics, and pleural drainage, though outcomes vary. In this case, pleural catheter placement offered temporary relief, but recurrent effusions led to hospice care. This case highlights the need for long-term monitoring in survivors of chest RT, as delayed pulmonary and cardiovascular toxicities can arise decades later. Given the rarity of DRPE and the lack of standardized treatment, further research into protective strategies and early interventions for radiation-induced lung injury is essential to improve cancer survivors' quality of life.
Keywords: delayed radiotherapy-related pleural effusions; non-hodgkin lymphoma; radiation-induced lung injury; radiation-induced pleural effusions; radiotherapy related pericardial effusion.
Copyright © 2025, Wagle et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
Imatinib-Induced Recurrent Pleural Effusions.Cureus. 2025 Apr 28;17(4):e83153. doi: 10.7759/cureus.83153. eCollection 2025 Apr. Cureus. 2025. PMID: 40443612 Free PMC article.
-
Pericardial and pleural effusions after definitive radiotherapy for esophageal cancer.J Radiat Res. 2012;53(3):447-53. doi: 10.1269/jrr.11194. J Radiat Res. 2012. PMID: 22739014
-
Delayed Onset of Pleural Effusion After Thoracic Radiation Therapy for Hodgkin Lymphoma: A Case Report With Over 30-Year Follow-Up.Cureus. 2022 Jul 22;14(7):e27138. doi: 10.7759/cureus.27138. eCollection 2022 Jul. Cureus. 2022. PMID: 36017284 Free PMC article.
-
Malignant effusive disease of the pleura and pericardium.Chest. 1997 Oct;112(4 Suppl):291S-295S. doi: 10.1378/chest.112.4_supplement.291s. Chest. 1997. PMID: 9337306 Review.
-
Serous effusions in malignant lymphomas: a review.Diagn Cytopathol. 2006 May;34(5):335-47. doi: 10.1002/dc.20432. Diagn Cytopathol. 2006. PMID: 16604559 Review.
References
-
- Radiotherapy for cancer: present and future. Allen C, Her S, Jaffray DA. Adv Drug Deliv Rev. 2017;109:1–2. - PubMed
Publication types
LinkOut - more resources
Full Text Sources